Chen Qiuyan, Zhang Shuxia, Liu Wenxiu, Sun Xiao, Luo Yun, Sun Xiaobo
Institute of Medicinal Plant Development, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, China.
Beijing Key Laboratory of Innovative Drug Discovery of Traditional Chinese Medicine (Natural Medicine) and Translational Medicine, Beijing, China.
Front Neurol. 2024 Jun 10;15:1400469. doi: 10.3389/fneur.2024.1400469. eCollection 2024.
Stroke is a primary cause of noncommunicable disease-related death and disability worldwide. The most common form, ischemic stroke, is increasing in incidence resulting in a significant burden on patients and society. Urgent action is thus needed to address preventable risk factors and improve treatment methods. This review examines emerging technologies used in the management of ischemic stroke, including neuroimaging, regenerative medicine, biology, and nanomedicine, highlighting their benefits, clinical applications, and limitations. Additionally, we suggest strategies for technological development for the prevention, diagnosis, and treatment of ischemic stroke.
中风是全球非传染性疾病相关死亡和残疾的主要原因。最常见的形式是缺血性中风,其发病率正在上升,给患者和社会带来了巨大负担。因此,需要采取紧急行动来解决可预防的风险因素并改进治疗方法。本综述探讨了用于缺血性中风管理的新兴技术,包括神经影像学、再生医学、生物学和纳米医学,强调了它们的益处、临床应用和局限性。此外,我们还提出了缺血性中风预防、诊断和治疗技术发展的策略。